TAUOPATHIES
Clinical trials for TAUOPATHIES explained in plain language.
Never miss a new study
Get alerted when new TAUOPATHIES trials appear
Sign up with your email to follow new studies for TAUOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets brain inflammation in early Alzheimer's patients
Disease control CompletedThis Phase 2 study tested whether XPro1595 could help people with early Alzheimer's disease who show signs of brain inflammation. The trial involved 208 participants aged 50-85 who received either the drug or a placebo for 24 weeks. Researchers measured changes in memory, thinkin…
Matched conditions: TAUOPATHIES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 03:27 UTC
-
Simple blood test could revolutionize Alzheimer's diagnosis
Diagnosis CompletedThis study tested whether specific proteins in the blood can accurately diagnose Alzheimer's disease. Researchers compared blood test results from 342 patients with results from the current standard spinal fluid test and clinical assessments. The goal was to see if a less invasiv…
Matched conditions: TAUOPATHIES
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC